JUNIPER PHARMACEUTICALS INC's ticker is JNP and the CUSIP is 48203L107. A total of 48 filers reported holding JUNIPER PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $113,000 | – | 11,163 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 328,133 | $1,838,000 | 1.22% |
| Stonepine Capital Management, LLC | 228,392 | $1,279,000 | 0.76% |
| Krensavage Asset Management, LLC | 290,853 | $1,629,000 | 0.58% |
| ALGERT GLOBAL LLC | 84,045 | $471,000 | 0.14% |
| HEARTLAND ADVISORS INC | 400,000 | $2,240,000 | 0.12% |
| TFS CAPITAL LLC | 16,912 | $95,000 | 0.02% |
| Spark Investment Management LLC | 50,500 | $282,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 180,200 | $1,009,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 20,792 | $116,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 24,390 | $137,000 | 0.00% |